Laser Photonics Corp. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
01 oct. 2024 11h56 HE
|
Block & Leviton LLP
Block & Leviton is investigating Laser Photonics Corp (Nasdaq: LASE) for potential securities fraud. Investors who have lost money should contact the firm.
SHAREHOLDER ALERT: iLearningEngines Investigated for Securities Fraud Violations by Block & Leviton
12 sept. 2024 16h04 HE
|
Block & Leviton LLP
Block & Leviton is investigating iLearningEngines (Nasdaq: AILE) for potential securities fraud. Investors who have lost money should contact the firm.
Eguana Announces Second Quarter 2024 Financial Results
29 août 2024 16h00 HE
|
Eguana Technologies Inc.
CALGARY, Alberta, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Eguana Technologies Inc. (TSXV: EGT) (OTCQB: EGTYF) (“Eguana” or the “Company”), a leading provider of high-performance energy storage systems,...
SHARC Energy Announces Q2 2024 Financial Results
29 août 2024 08h00 HE
|
SHARC Energy
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ("SHARC Energy" or the “Company”) is pleased to announce it has...
Novonesis delivers strong half-year results and increases full-year outlook
27 août 2024 10h34 HE
|
Novozymes A/S
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...
Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis For the Six Months Ended 30 June 2024
15 août 2024 02h00 HE
|
Cornish Metals Inc.
Cornish Metals releases unaudited financial statements and management's discussion and analysis for the six months ended 30 June 2024
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
14 août 2024 16h05 HE
|
Fractyl Health, Inc.
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
08 août 2024 16h05 HE
|
Assembly Biosciences, Inc.
Dosing initiated in healthy participants in Phase 1a/b trial for ABI-5366 targeting recurrent genital herpes, with interim Phase 1a first-in-human data expected in Q3 2024 and interim Phase 1b data in...
Orezone Reports Second Quarter 2024 Results
06 août 2024 18h32 HE
|
Orezone Gold Corporation
VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the three...
Orezone Provides Notice of Q2-2024 Results and Conference Call
29 juil. 2024 12h23 HE
|
Orezone Gold Corporation
VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its second quarter 2024 results on August 6, 2024, after...